Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Invested Capital (2019 - 2025)

Legend Biotech filings provide 7 years of Invested Capital readings, the most recent being $1.0 billion for Q1 2025.

  • On a quarterly basis, Invested Capital fell 12.57% to $1.0 billion in Q1 2025 year-over-year; TTM through Mar 2025 was $1.0 billion, a 12.57% decrease, with the full-year FY2024 number at $1.3 billion, down 14.04% from a year prior.
  • Invested Capital hit $1.0 billion in Q1 2025 for Legend Biotech, down from $1.3 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.5 billion in Q4 2023 to a low of $206451.0 in Q1 2021.
  • Median Invested Capital over the past 5 years was $1.1 billion (2024), compared with a mean of $909.2 million.
  • Biggest five-year swings in Invested Capital: surged 358900.44% in 2022 and later fell 17.63% in 2024.
  • Legend Biotech's Invested Capital stood at $878.7 million in 2021, then skyrocketed by 30.11% to $1.1 billion in 2022, then surged by 31.32% to $1.5 billion in 2023, then fell by 14.04% to $1.3 billion in 2024, then dropped by 21.14% to $1.0 billion in 2025.
  • The last three reported values for Invested Capital were $1.0 billion (Q1 2025), $1.3 billion (Q4 2024), and $1.1 billion (Q3 2024) per Business Quant data.